Adipose-Derived Mesenchymal Stem Cell Therapy for Reverse Bleomycin-Induced Experimental Pulmonary Fibrosis

MSCs were obtained from mice and characterized using flow cytometry and cell differentiation culture methods. Then adult C57BL/6 mice were exposed to endotracheal instillation of bleomycin and concurrently treated with MSCs for reversal models on day 14.